Dolby Laboratories
✦ Quant Fair Value how this is computed
- Implied fair-value range of 70.78-106.86, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is -37.7% below the average-multiple fair value of 88.82.
Valuation each multiple against its own 5-year range
Vs. peers Specialty Business Services
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Dolby Laboratories (DLB) | 5.13B | 20.49 | 1.97 | 2.60% |
| Cintas (CTAS) | 87.36B | 43.39 | 16.79 | 0.85% |
| RELX PLC (RELX) | 66.86B | 23.66 | 41.26 | 2.30% |
| Thomson Reuters (TRI) | 44.02B | 28.04 | 3.92 | 2.54% |
| Copart (CPRT) | 28.80B | 20.06 | 3.17 | 0.00% |
| Global Payments (GPN) | 24.30B | -19.71 | 1.05 | 1.09% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 31.9% below Morningstar's fair value estimate.
Fair value
Dolby Laboratories Inc earns a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 13% discount to our quantitative fair value estimate of $72.98 per share, which is reinforced by this estimate's low uncertainty rating.
The company's balance sheet bolsters our valuation estimate. Low leverage mitigates financial risk, potentially boosting a firm's value. For example, the firm's debt to EBITDA ratio of 0.1 falls in the bottom 10% compared with global peers. Without much debt relative to assets, this company should exhibit high resilience should the global economy weaken; if not, the company could raise debt and invest in the business or return capital to shareholders. We believe this is a sign that shares could be undervalued.
Conversely, the company's lack of profitability is potentially concerning. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's sales yield of 21.7%, for example, lies in the bottom 20% compared with global peers. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which, despite our favorable price/fair value ratio, is a negative attribute.
Economic moat
The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.
By Quantitative Equity Report
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Dolby Laboratories discussion 0 comments